Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Toxicology

• Publication date

  2000-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0300-483X(00)00312-7PMID 11090955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholinergic strategies for Alzheimer’s disease

  1998cited by this paper
• Acetylcholine, aging, and Alzheimer's disease.

  1997cited by this paper
• Changes in cholinergic neurons and failure in learning function after microsphere embolism-induced cerebral ischemia.

  1997cited by this paper
• Failure in learning task and loss of cortical cholinergic fibers in microsphere-embolized rats

  1997cited by this paper
• Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats.

  1996cited by this paper
• Platelets and shear stress.

  1996cited by this paper
• Developmental change of kidney dopamine receptors in spontaneously hypertensive rats.

  1995cited by this paper
• ANIMAL MODELS OF VASCULAR DEMENTIA WITH EMPHASIS ON STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS

  1995cited by this paper
• Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.

  1994cited by this paper
• (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

  1991cited by this paper
• Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis.

  1990cited by this paper
• Behavioral and Neurochemical Evaluation of Stroke-Prone Spontaneously Hypertensive Rats for Vascular Dementia-Animal Model

  1990cited by this paper
• Shear-induced platelet aggregation.

  1990cited by this paper
• Increased Sodium‐Calcium Exchange in Arterial Smooth Muscle of Spontaneously Hypertensive Rats

  1989cited by this paper
• AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.

  1984cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Prophylactic Approach to Hypertensive Diseases

  1979cited by this paper
• Establishment of the strokeprone spontaneously hypertensive rat (SHR)

  1972cited by this paper
• Development of a strain of spontaneously hypertensive rats.

  1963cited by this paper

• [Animal experimental models in the study of age-dependent cerebral microangiopathy].

  2025cites this paper
• Connectome-based prediction of functional impairment in experimental stroke models

  2024cites this paper
• Immune system activation and cognitive impairment in arterial hypertension

  2024cites this paper
• Connectome-based prediction of functional impairment in experimental stroke models

  2023cites this paper
• Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations

  2022cites this paper
• Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy

  2022cites this paper
• Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review

  2021cites this paper
• Microstructural disruption of the right inferior fronto‐occipital and inferior longitudinal fasciculus contributes to WMH‐related cognitive impairment

  2020cites this paper
• A Vessel for Change: Endothelial Dysfunction in Cerebral Small Vessel Disease.

  2020influential citation
• Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model

  2020cites this paper
• Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

  2020cites this paper
• Posterior reversible encephalopathy syndrome in stroke-prone spontaneously hypertensive rats on high-salt diet

  2019cites this paper
• Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit

  2019cites this paper
• Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit

  2019cites this paper
• Comparative analysis of cognitive impairment prevalence and its etiological subtypes in a rural area of northern China between 2010 and 2015

  2019cites this paper
• Hypertension and Its Impact on Stroke Recovery: From a Vascular to a Parenchymal Overview

  2019cites this paper
• Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy

  2018cites this paper
• Carotid artery stenosis in hypertensive rats impairs dilatory pathways in parenchymal arterioles.

  2018cites this paper
• Unraveling the heterogeneity of cerebral small vessel disease. From local to remote effects

  2018cites this paper
• Frailty and Vascular Cognitive Impairment: Mechanisms Behind the Link.

  2016cites this paper
• Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.

  2016cites this paper
• Inhibited Expression of α4β2 Nicotinic Acetylcholine Receptor in Blood Leukocytes of Chinese Patients with Vascular Dementia and in Blood Leukocytes as Well as the Hippocampus of Brain from Ischemic Rats

  2016cites this paper
• Dynamics of the cerebral microvasculature during the course of memory consolidation in the rat : physiological and altered conditions induced by hypertension and hypergravity

  2016cites this paper
• The Effects of Hypertension on Cerebral Artery Structure and Function, and Cerebral Blood Flow

  2016cites this paper
• (-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model

  2016cites this paper
• White matter hyperintensities, cognitive impairment and dementia: an update

  2015cites this paper
• Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.

  2014cites this paper
• Regional Cerebral Blood Flow and Arterial Blood Volume and Their Reactivity to Hypercapnia in Hypertensive and Normotensive Rats

  2014cites this paper
• Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement

  2014cites this paper
• Pathophysiological rat model of vascular dementia: magnetic resonance spectroscopy, microimaging and behavioral study.

  2014cites this paper
• Effect of hypertension on the structural and functional integrity of the young and aged brain in an inducible transgenic model

  2014cites this paper
• Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL

  2014cites this paper
• The effects of hypertension on the cerebral circulation.

  2013cites this paper
• Exercise training plus calorie restriction causes synergistic protection against cognitive decline via up-regulation of BDNF in hippocampus of stroke-prone hypertensive rats

  2012cites this paper
• Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats.

  2012cites this paper
• Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior.

  2012cites this paper
• Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats.

  2012cites this paper
• Galantamine administration in chronic post-stroke aphasia

  2012cites this paper
• Protective effects of acetyl-L-carnitine on neurodegenarative changes in chronic cerebral ischemia models and learning-memory impairment in aged rats

  2012influential citation
• A Review of Transcranial Magnetic Stimulation in the in vivo Functional Evaluation of Central Cholinergic Circuits in Dementia

  2011cites this paper
• Hypotension in Subcortical Vascular Dementia, a New Risk Factor – Wasn’t It Hypertension?

  2011cites this paper
• Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study

  2011cites this paper
• Cerebral small vessel endothelial structural changes predate hypertension in stroke‐prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5‐ to 21‐week‐old rats

  2011cites this paper
• A Review of Transcranial Magnetic Stimulation in Vascular Dementia

  2011cites this paper
• Pharmacotherapy and prevention of vascular dementia.

  2011cites this paper
• Correlations Between Cholinesterase Activity and Cognitive Scores in Post-Ischemic Rats and Patients with Vascular Dementia

  2011influential citation
• Choline alphoscerate pharmacology and its role in the treatment of cognitive impairment related to neurological disorders

  2011cites this paper
• Experimental models of vascular dementia and vascular cognitive impairment: a systematic review

  2010cites this paper
• Management of Mixed Dementia

  2010cites this paper
• Spontaneously hypertensive rat neuroanatomy: applications to pharmacological research.

  2010influential citation
• The expression of matrix metalloproteinase-13 is increased in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model

  2009cites this paper
• Vascular cognitive impairment: dementia biology and translational animal models.

  2009cites this paper
• Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment

  2009cites this paper
• Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat

  2009cites this paper
• The Pathology of “Vascular Dementia”: A Critical Update

  2008cites this paper
• Morphologic diagnosis of "vascular dementia" - a critical update.

  2008cites this paper
• Risk factors for vascular dementia: Hypotension as a key point

  2008cites this paper
• Vascular damage and EEG markers in subjects with mild cognitive impairment.

  2007cites this paper
• New treatment options for vascular dementia

  2007cites this paper
• Rivastigmine and Parkinson dementia complex

  2007cites this paper
• The enigma of vascular cognitive disorder and vascular dementia

  2007cites this paper
• Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.

  2006cites this paper
• Increased HO-1 expression and decreased iNOS expression in the hippocampus from adult spontaneously hypertensive rats

  2006cites this paper
• Vascular cognitive impairment

  2006cites this paper
• Animal models of cognitive dysfunction.

  2006cites this paper
• Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

  2006cites this paper
• Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats.

  2006cites this paper
• Vascular dementia: prevention and treatment

  2006cites this paper
• ΠΑΝΕΠΙΣΤΗΜΙΟ ΠΑΤΡΩΝ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ

  2005cites this paper
• Therapy of vascular dementia: perspectives and milestones

  2005cites this paper
• Dietary approach to decrease aging-related CNS inflammation

  2005cites this paper
• Poststroke Dementia

  2005cites this paper
• Cerebrovascular damage as a cause for Alzheimer's disease.

  2005cites this paper
• Poststroke dementia.

  2005cites this paper
• Understanding the pathology of vascular cognitive impairment.

  2005cites this paper
• Poststroke Dementia in the Elderly

  2005cites this paper
• Rivastigmine in vascular dementia

  2004cites this paper
• Pathology and pathophysiology of vascular cognitive impairment. A critical update.

  2004cites this paper
• Avances en la fisiopatología de la demencia vascular

  2004cites this paper
• The effect of a dietary phase 2 protein inducer on inflammatory parameters in blood and liver of spontaneously hypertensive stroke prone rats

  2004cites this paper
• Cholinesterase Inhibitors and Vascular Dementia

  2004cites this paper
• An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.

  2003cites this paper
• Efficacy and Tolerability of Donepezil in Vascular Dementia : Positive Results of a

  2003cites this paper
• Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia

  2003cites this paper
• Long‐term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease

  2003cites this paper
• Galantamine in the Treatment of Vascular Dementia

  2003cites this paper
• Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients

  2003cites this paper
• GALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA

  2003cites this paper
• Donepezil in vascular dementia

  2003cites this paper
• Clinical Pharmacokinetics of Galantamine

  2003cites this paper
• Editorial comment--How to treat vascular dementia?

  2003cites this paper
• Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

  2003cites this paper
• Arterial Hypertension and Brain Damage—Evidence from Animal Models (Review)

  2003cites this paper
• Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial

  2003cites this paper
• [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].

  2003cites this paper
• Rivastigmine in Vascular Dementia

  2003cites this paper
• Management of Patients with Alzheimer’s Disease plus Cerebrovascular Disease: 12-Month Treatment with Galantamine

  2003cites this paper
• Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats.

  2002cites this paper
• The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.

  2002cites this paper
• Non‐cognitive benefits of galantamine (Reminyl®) treatment in vascular dementia

  2002cites this paper